In short
These medicines usually start at a low dose and step up. The first doses are not the full dose. With weekly dosing, the amount in the body builds over several weeks before it levels out. The label, and your prescriber, give the schedule. This article gives no doses; the steps are on the labels. Reko records your doses and how you feel, so you can see change as it happens.
Why it is not instant
Most of these medicines are started low and raised in steps. This gives the body time to adjust. It also means the first weeks are not at the dose that may eventually be used. The step schedule is set by the label and your prescriber: on the U.S. labels, Ozempic goes up after 4 weeks on its starting dose, Wegovy injection goes up every 4 weeks over its first 16 weeks, and Mounjaro and Zepbound go up in 2.5 mg steps after at least 4 weeks on the current dose (Mounjaro, Zepbound, Ozempic, Wegovy).
Why it builds up
A drug that leaves the body slowly, taken once a week, accumulates before it settles into a steady pattern. The time this takes depends on its half-life: semaglutide has a half-life of approximately 1 week and reaches steady state after 4 to 5 weeks of weekly doses (Ozempic label), and tirzepatide has a half-life of approximately 5 days, or 5 to 6 days on the Zepbound label, with steady state after 4 weeks. Reko draws an estimated level from your doses and the compound's published half-lives, so you can see the shape. It is an estimate, not a blood test.
When effects show up
Effects on appetite, on weight and on blood sugar do not all arrive together. Label and trial data describe when they were measured in studies: in adults with obesity or overweight and no diabetes, the Wegovy label reports an average body-weight change of -14.9% on Wegovy against -2.4% on placebo at week 68, and the Zepbound label reports -15.0%, -19.5% and -20.9% on 5, 10 and 15 mg against -3.1% on placebo at week 72. In type 2 diabetes, the Mounjaro label reports HbA1c falling by 1.8, 1.7 and 1.7 points on 5, 10 and 15 mg against 0.1 on placebo at 40 weeks. Individual results differ widely. Do not compare your week three with someone else's.
What can change the timing
- The dose and where you are in the step schedule.
- Missed or late doses.
- Other medicines and health conditions.
- Food, sleep, activity and hydration.
Your prescriber is the right person to ask whether your progress is as expected.
What to record while you wait
- Every dose, with the date and site.
- Weight, on the same terms each time.
- Side effects, beside the dose they followed. How.
- Protein, water and food against your own targets.
When you see your care team, a few weeks of notes tell a better story than memory does.
Questions
How long does it take to reach a steady level?
The U.S. labels say steady state comes after 4 to 5 weeks of weekly doses on Ozempic and after 4 weeks on Mounjaro and Zepbound.
What if I have lost little by week 24?
An EMA report on SURMOUNT-1 says that of people who had lost under 5% at week 24, 53%, 68% and 72% on 5, 10 and 15 mg still reached 5% by week 72, against 13% on placebo. Talk to your prescriber about your own case.
Should I raise my dose if I see no change?
That is a decision for your prescriber. Reko never suggests a dose.
Is the level curve a measurement?
No. It is an estimate from your logged doses and published half-lives.
Do the first doses start at the full dose?
No. These medicines usually start at a low dose and step up, so the first weeks are not at the dose that may eventually be used. On the U.S. labels, Ozempic goes up after 4 weeks on its starting dose, and Mounjaro and Zepbound go up in 2.5 mg steps after at least 4 weeks on the current dose. Your prescriber sets your schedule.
Why does it take weeks for the level to settle?
A drug that leaves the body slowly, taken once a week, accumulates before it settles into a steady pattern. Semaglutide has a half-life of approximately 1 week and tirzepatide approximately 5 days, so the amount in the body builds over several weeks.
Do effects on weight and blood sugar arrive at the same time?
Not necessarily. Label data describe when effects were measured in studies, such as week 68 or 72 for body weight and 40 weeks for HbA1c on Mounjaro. Individual results differ widely, so do not compare your week three with someone else's.
Read next
Useful tools
- Mounjaro prescribing information on DailyMed (Eli Lilly and Company, Novo Nordisk). Checked 2 November 2026.
- Zepbound prescribing information on DailyMed (Eli Lilly and Company, Novo Nordisk). Checked 2 November 2026.
- Ozempic prescribing information on DailyMed (Eli Lilly and Company, Novo Nordisk). Checked 2 November 2026.
- Wegovy prescribing information on DailyMed (Eli Lilly and Company, Novo Nordisk). Checked 2 November 2026.
- EMA Mounjaro assessment report, on SURMOUNT-1.